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Marianne Dieterich, Univ. Prof. Dr. med.,†|| and Claas Lahmann, Univ. Prof. Dr. med.¶Abstract: Despite the frequent observation that vertigo and dizziness (VD) dis-
orders may trigger or exacerbate secondary psychiatric comorbidities, there is
limited understanding of the mechanisms underlying this development. To ad-
dress this gap, we investigated whether symptom-related fears and cognitions
as indicated by questionnaire-based measures are mediators of the longitudinal
effect of VD symptoms on anxiety and depression after 1 year. We analyzed data
from a large study with patients of a treatment center specialized in vertigo
(N = 210). Simple and multiple parallel mediation models strengthened our hy-
pothesis that fear of bodily sensations and cognitions about these symptoms play
a mediating role in the relationship between VD symptoms and psychopathology
at follow-up after baseline scores of the outcome were controlled for. Results are
discussed within a cognitive theory framework and point to the potential benefits
of interventions that modify symptom-related beliefs and fears via cognitive psy-
chotherapy in this therapeutically underserved population.
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V ertigo and dizziness (VD) rank among the most common symp-toms in adults with a lifetime prevalence of approximately 30%
(Neuhauser, 2007; Tusa, 2009). The underlying causes of those
symptoms vary largely, ranging from peripheral and central vestibular
disorders or other organic causes to somatoform disorders and all com-
binations thereof. Irrespective of their etiology, VD symptoms are often
experienced as severely distressing. They are associated with handicap
in daily and working lives (Lahmann et al., 2015; Yardley et al., 1992)
as well as a significant reduction of both mental and physical health-
related quality of life (Weidt et al., 2014). Subjective impairment and
health care use due to their VD are further increased if patients are char-
acterized by psychiatric comorbidity (Lahmann et al., 2015; Wiltink
et al., 2009). Not only do they show a higher persistency of symptoms
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(Probst et al., 2017). More often than not VD symptoms have been
linked to such psychiatric comorbidity, regardless of whether studies
were conducted from the vantage point of vestibular deficits or psycho-
pathology (Best et al., 2009a; Bigelowet al., 2015; Staab andRuckenstein,
2003). The highest rates of psychiatric comorbidity have been reported
for vestibular migraine, Ménière’s disease, vestibular paroxysmia,
and functional VD (Eckhardt-Henn et al., 2008; Lahmann et al.,
2015). Furman et al. (2005) suggested neuroanatomical connections
between vestibular stimuli and the emotional response processing
system to explain the comorbidity of VD and psychiatric disorders.
However, cross-sectional studies found that emotional distress was in-
dependent of the amount of vestibular deficit (Best et al., 2006; Pérez
et al., 2003). The extent of vestibular dysfunction also had no impact
over the course of time on the development of secondary psychiatric
disorders (Best et al., 2009a; Eagger et al., 1992). On that account,
the study at hand focuses on the question as to what does act as the
intermediary between VD symptoms and the development or exacer-
bation of psychological distress.
Cognitive theory suggests that dysfunctional cognitions con-
tribute to psychological distress in a causal manner (e.g., Beck,
2005), an association that was corroborated in a recent meta-analysis
(Vîslă et al., 2016). With regard to VD, patients frequently present
with individual patterns of thoughts and feelings related to their VD
symptoms that fulfil the B criterion of the Diagnostic and Statistical
Manual of Mental Disorders, 5th Edition, somatic symptom disorder
(Limburg et al., 2016); these may include disproportionate thoughts
about the symptoms' seriousness, a persisting high level of anxiety
about health or symptoms, and excessive time and energy devoted to
these symptoms or health concerns (American Psychiatric Association
[APA], 2013). Cognition has been described as a potent modulator of so-
matic and psychological symptoms via processes such as somatosensory
amplification (Barsky, 1992). This concept describes an altered percep-
tion of somatic stimuli that includes a heightened attentional focus on
bodily sensations and a tendency to appraise them as intense, alarming,
and signs of a threatening disease. Somatosensory amplification reflects
aspects of cognitive processing rather than mere interoceptive sensitivity;
it has been proposed to explain some of the variability in somatic symp-
tomatology found among different patients with the same medical disor-
der and one factor mediating the link between somatic and psychological
symptoms (Nakao and Barsky, 2007).
Recent theoretical models have taken a closer look at the inter-
play between interoceptive and self-referential cognitive processes with
regard to anxiety and depression and suggested that “external cues or
internal thought processes might generate an anticipation of aversive
body states that […] [act] as a motivating signal for individuals towith-
draw (depression) or avoid (anxiety).” (Paulus and Stein, 2010, p 456).
That is, if bodily symptoms such as VD are experienced as particularly
troubling, potentially uncontrollable, or persistent, this appraisal guides
action planning and may thereby contribute to a negative self-view, for, April 2018 www.jonmd.com 277
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creased attentional bias toward indicators of potential threat associated
with avoidance behavior (anxiety). With regard to catastrophic thinking
of this sort (i.e., the tendency to overinterpret the likelihood or intensity
of potential negative consequences of symptoms, misinterpretation of
somatic sensations as signs of a serious illness, or ruminating about
worst-case outcomes), there is extensive literature on its correlational
and predictive value in a variety of disorders (Gellatly and Beck, 2016).
However, only few studies have investigated the role of symptom-related
cognitions in patients presenting with VD: in their prospective study on
patients with an acute episode of vestibular neuritis, Godemann et al.
found catastrophic thinking, persistent fear of vertigo, and panic-related
thoughts to predict chronic vertigo (Godemann et al., 2004) and the
development of secondary somatoform and panic disorder (Godemann
et al., 2006). Another study demonstrated that for the development of
secondary somatoform dizziness after a peripheral vestibular disorder,
the fear of bodily sensationswas relevant in the interaction with the initial
severity of dizziness (Heinrichs et al., 2007). In Ménière’s disease, mal-
adaptive beliefs about the consequences of VD even appeared to be more
disabling than symptoms themselves (Yardley et al., 2001).
Although the aforementioned studies mainly focused on the role
of symptom-related fears and beliefs in the development or perpetua-
tion of (somatoform) VD symptoms, there is, to our knowledge, a lack
of investigations on how fears and cognitions contribute to the effect
VD symptoms longitudinally exert on the development of anxiety and
depression. Previous studies on this issue have almost exclusively
focused on patients with Ménière’s disease. Illness uncertainty/
unpredictability and illness intrusiveness have been discussed as fac-
tors contributing to depression in these patients (Arroll et al., 2012).
With regard to anxiety, Kirby and Yardley (2009) found that vertigo
can lead to increased anxiety, if patients with Ménière’s disease reported
high intolerance of uncertainty and less understanding of their illness.
The scarcity of investigations in that area is of particular concern
because current psychotherapeutic efforts may be effective in reducing
VD symptoms but mostly failed to achieve clinically relevant improve-
ments concerning the frequently associated symptoms of anxiety or
depression (Schmid et al., 2011).
Aim of the study. The current study seeks to explore whether the
longitudinal effect of VD symptoms (assessed at baseline) on anxiety and
depression (assessed at 12-month follow-up) is mediated by symptom-
related fears and cognitions (assessed at the 6-month follow-up). We
therefore reanalyzed data from a large study with patients of a treatment
center specialized in vertigo covering a variety of VD disorders (Lahmann
et al., 2012).
Hypothesis. We hypothesized that fear of bodily sensations and
cognitions about these symptoms would longitudinally mediate the
effect initial VD symptoms have on the development of anxiety
and depression.
METHODS
Study Design and Sample Characteristics
This longitudinal study encompasses three assessment points:
baseline (t0), first follow-up after 6 months (t1), and second follow-up
after 12 months (t2). Patients were recruited via routine care appoint-
ments at the German Centre for Vertigo and Balance Disorders at the
University Hospital Munich, Campus Großhadern, between May 2010
and June 2012. All patients had been referred with dizziness or imbal-
ance as their primary complaint. Patients were excluded if they were less
than 18 years of age, had no sufficient German language skills, or had a
neurodegenerative disorder (e.g., dementia). A total of 686 (≈80%) of
860 eligible patients gave their consent to participate in the study. There
were 350 and 360 patients who took part in the first and second follow-
up assessment, respectively.278 www.jonmd.com
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ing questionnaires could be computed were analyzed: Vertigo Symptom
Scale (VSS; vertigo subscale) at t0, Body Sensations Questionnaire
(BSQ), and Agoraphobic Cognitions Questionnaire (ACQ) at t1, Beck
Depression Inventory (BDI–II), and Beck Anxiety Inventory (BAI) at
t2. A total of 210 patients fulfilled this inclusion criterion. Patients that
were excluded from the analyses did not differ from included patients
with regard to sex distribution or any of the questionnaire-basedmeasures
at baseline. However, excluded patients were significantly younger
(included: mean = 57.4 yrs [SD = 15.6]; excluded: mean = 54.4 yrs
[SD = 16.3]; t[685] = 2.30, p = 0.022, Hedges’ g = 0.18).
This study was part of the Munich Diagnostic and Predictor
Study of Somatoform Dizziness, which is described in detail elsewhere
(Lahmann et al., 2012). All participants gave written informed consent,
and the study was approved by the ethics committee of the University
of Munich.
Diagnostic Assessment and Patient
Self-Report Questionnaires
All patients underwent structured collection of their histories and
a systematic and standardized physical examination, including complete
neurological, neurootological, and neuroophthalmological examination.
Vestibular testing included the head impulse test, measurements of
subjective visual vertical and ocular torsion, and video-oculography
with caloric irrigation. Frequencies of respective diagnoses are listed
in the Results section. The following self-report questionnaires were
administered to patients:
(1) VD symptoms. VD symptoms were assessed using the VSS
(Yardley et al., 1992). The VSS (German version by Tschan et al., 2008)
consists of two scales measuring vertigo-balance symptoms (VSS-VER;
e.g., dizziness, unsteadiness, and light-headedness) and vertigo-induced
autonomic-anxiety symptoms (VSS-AA; e.g., sweating, pounding heart,
and breathing difficulties). In the present study, only the VSS-VER score
was analyzed. It comprises 19 items scored on a 5-point Likert scale
ranging from 0 (never) to 4 (more than once a week). The VSS shows
good test-retest reliability and construct validity (Yardley et al.,
1992; Tschan et al., 2008). For the 210 patients of the present study, the
Cronbach's alpha of the VSS-VER scale at t0 was α = 0.86.
(2) Anxiety and depression. Psychological distress, namely, symp-
toms of anxiety and depressive disorders, was assessed using the BAI
(German version by Margraf and Ehlers, 2007) and the revised BDI–II
(German version by Hautzinger et al., 2006). The BDI–II assesses de-
pression severity during the past 2 weeks; 21 Items are rated on a 4-point
scale (0–3). It is a psychometrically sound instrument (Kühner et al.,
2007) with a Cronbach’s alpha of α = 0.92 at t2 in our sample. The BAI
is composed of 21 items measuring severity of anxiety symptoms during
the last 7 days. Items are scored on a 4-point Likert scale ranging from
0 (not at all) to 3 (strongly). The inventory shows good reliability
and validity (Margraf and Ehlers, 2007). The BAI at t2 reached a
Cronbach's alpha of α = 0.93 in our sample.
(3) Cognitions and fears with regard to bodily symptoms. To
assess the fear of physical symptoms and panic-related cognitions, the
BSQ and the ACQ out of a questionnaire series by Chambless et al.
(1984) were applied in their German version (Ehlers and Margraf,
2001). The BSQ is composed of 17 items measuring the intensity of fear
with respect to body sensations (e.g., vertigo, palpitations, and feeling of
not being able to breathe). On a 5-point Likert scale, patients indicate to
which extent they worry about a particular symptom, ranging from 1
(not at all anxious) to 5 (extremely anxious). The ACQ is a 14-item
questionnaire designed to measure maladaptive thoughts about the
potential for catastrophic consequences arising from anxiety or panic.
Thoughts such as “I will have a heart attack” or “I will not be able to
control myself” are rated on a 5-point Likert scale (1—the thought never
occurs to me; 5—the thought always occurs to me). Two subscales can be© 2018 Wolters Kluwer Health, Inc. All rights reserved.
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items). Overall, the German versions of the BSQ and ACQ scales
showed good internal consistency and reliability. The Cronbach’s
alphas of both questionnaires were high in our sample (BSQ at t1:
α = 0.93; ACQ at t1: α = 0.81). The ACQ subscales had acceptable re-
liability (ACQ physical crisis at t1: α = 0.72; ACQ loss of control at
t1: α = 0.76).FIGURE 1. Diagrams of mediation models. (A) Simple mediation model
investigating symptom-related fears as a mediator between VD
symptoms and depression. (B) Simple mediation model investigating
symptom-related cognitions as a mediator between VD symptoms and
depression. (C) Multiple parallel mediation model investigating both
symptom-related fears and cognitions as mediators between VD
symptoms and depression. (D) Multiple parallel mediation model
investigating physical concerns and loss of control as mediators
between VD symptoms and depression. Mediationmodels with regard to
anxiety symptoms as outcome variable (t2) were defined accordingly.Statistical Analyses
All statistical analyses were performed using SPSS 22 statistical
package. To test for differences among included versus excluded patients
with regard to sex, age, and self-report questionnaire scores, categorical
variables were analyzed using the chi-square tests, and continuous base-
line variables were analyzed using independent samples t-tests. Pearson
correlation coefficients were calculated to assess the correlations between
the measures analyzed in the study; Bonferroni correction was applied to
correct for multiple testing.
To evaluate the mediating role of symptom-related fears and cog-
nitions (BSQ, ACQ, and its subscales) at t1 in the relationship between
VD symptoms (VSS-VER) at t0 and psychological distress (BDI–II,
BAI) at t2, model 4 within PROCESS (Hayes, 2013), a macro for SPSS
for moderation and mediation analyses, was used. PROCESS uses
bootstrapping to estimate confidence intervals (CIs) of indirect effects
(IEs). For all mediation analyses in the present study, the bias-corrected
bootstrap CI method was selected with 10.000 bootstrap samples. To
correct for multiple testing, the confidence level for CI was set to
98.75%, taking into account that four mediation models were calcu-
lated for each outcome measure. Completely standardised indirect
effects (CS) (Preacher and Kelley, 2011) were computed as a measure
of effect size and considered small if 0.01 ≤ CS < 0.09, medium if
0.09 ≤ CS < 0.25, and large if CS ≥ 0.25. The p value was set to
p < 0.05 in all analyses. Before analyses, bivariate scatterplots of
the antecedent, mediator, and consequent variables were examined to
evaluate the assumption of linear relations. To test for multicollinearity,
variance inflation factors (VIFs) were computed for every step in the
mediation analyses; with all VIF less than 1.6, it is unlikely that
this might have introduced substantial error to coefficient estimates of
individual predictors.
Because the subsample the analyses are based on differed from
the excluded part of the sample in terms of age, it was included as
a covariate across mediation analyses. To control for baseline values
of the outcome measures, the BAI and BDI–II scores at the 12-month
follow-up were entered into separate univariate simple linear regression
analyses with their baseline scores serving as the independent variable,
respectively. Residuals from these analyses were used as outcome var-
iable in all further mediation models.
Two simple mediationmodels and twomultiple parallel mediation
models were calculated for each of the two outcome variables (BDI–II
and BAI at t2). Diagrams of the mediation models are illustrated in
Figure 1. In all mediation models, the VSS vertigo score at t0 was
entered as the independent variable.
First, simple mediation models evaluated symptom-related fears
(BSQ; model [A]) and symptom-related cognitions (ACQ; model [B]),
separately, as mediators of the effect that VD symptoms at baseline
exert on the respective outcome variable. Second, both ACQ and BSQ
were included in a multiple parallel mediation model [C] to evaluate
whether both measures remain significant mediators when statistically
controlling for the other one. Finally, model [D] contrasted the two
ACQ subscales in a multiple parallel mediationmodel to explorewhether
one of the two aspects of symptom-related cognitions outweighs the other
in mediating the relationship between VD symptoms and the outcome
measures. We note that model [D] was exploratory in nature and did
not correspond directly to the study hypothesis.© 2018 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2018 Wolters Kluwer HRESULTS
Characteristics and Diagnoses of the Study Sample
Of the 210 analyzed patients, 119 (57%) were female. The most
frequent diagnoses were functional VD (n = 71), benign paroxysmal
positional vertigo (n = 37), Ménière’s disease (n = 37), and vestibular
migraine (n = 31). More than one third of patients received more than
one diagnosis. Descriptive statistics of all questionnaire-based measures
are presented in Table 1. Across the diagnostic subgroups, 20% of pa-
tients (n = 42) showed moderate to severe levels of depression (BDI–II
score ≥ 20) at the second follow-up, and 32% (n = 66) showed moderate
to severe levels of anxiety according to their BAI scores (≥16) after 1 year.
Table 2 gives an overviewof the diagnoses and the respective descriptives
of the mediator variables of interest.Correlations Between the Measures
Pearson correlation coefficients between all the questionnaire-
based measures (VSS-VER at t0, ACQ at t1, BSQ at t1, BDI–II at t0www.jonmd.com 279
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VSS-VER 0.96 (0.71) 0.00–3.53
Symptom-related cognitions (t1)
ACQ 1.31 (.33) 1.00–3.07
ACQ physical crisis 1.37 (.46) 1.00–3.40
ACQ loss of control 1.30 (.40) 1.00–3.29
Symptom-related fears (t1)
BSQ 1.88 (.66) 1.00–4.41
Depression (t2)
BDI–II 11.90 (9.47) 0–47
Anxiety (t2)
BAI 12.85 (11.08) 0–56







Functional VD 71 (34%) 1.39 (0.400) 2.01 (0.524)
Benign paroxysmal positional vertigo 37 (18%) 1.28 (0.305) 1.81 (0.695)
Ménière’s disease 37 (18%) 1.26 (0.282) 1.88 (0.693)
Vestibular migraine 31 (15%) 1.34 (0.301) 1.86 (0.649)
Bilateral vestibulopathy 24 (11%) 1.26 (0.292) 1.67 (0.524)
Multisensory deficit 16 (8%) 1.24 (0.197) 1.93 (0.719)
Central vertigo 15 (7%) 1.38 (0.332) 1.97 (0.643)
Vestibular paroxysmia 13 (6%) 1.41 (0.330) 2.00 (0.617)
Polyneuropathy 12 (6%) 1.26 (0.187) 1.91 (0.587)
Vestibular neuritis 12 (6%) 1.24 (0.302) 1.77 (0.583)
Unilateral vestibular loss 8 (4%) 1.34 (0.420) 2.02 (0.867)
Not otherwise specified 26 (12%) 1.29 (0.320) 1.88 (0.746)
No. diagnoses
n = 1 135 (64%) 1.30 (0.340) 1.85 (0.671)
n = 2 56 (27%) 1.33 (0.332) 1.85 (0.640)
n = 3 19 (9%) 1.34 (0.278) 2.12 (0.624)
Radziej et al. The Journal of Nervous and Mental Disease • Volume 206, Number 4, April 2018and t2, and BAI at t0 and t2) are illustrated in Table 3. Correlations were
all positive and statistically significant.Mediation Analyses Between Vertigo Symptoms
and Depression
Throughout the mediation models, age did not contribute signif-
icantly to any of the regression analyses, that is, regression coefficients
for age as a covariate in the prediction of the mediator or outcome var-
iables failed to reach statistical significance. The results of the simple
mediation models analyzing the IE of vertigo symptoms on depression
after 1 year through symptom-related fears and cognitions (models [A]
and [B]) revealed that both variables of interest at t1 functioned as
significant mediators with the upper and lower levels of the CI of the
IE being above zero. With regard to symptom-related fears (BSQ), the
CS amounted to 0.06, indicating a small effect after baseline BDI–II
scores had been netted out (IE = 0.53, Boot SE = 0.25; Boot LLCI = 0.07,
Boot ULCI = 1.35). When symptom-related cognitions (ACQ) were
taken into account in a simple mediation model, a CS of 0.11 indicated
a medium effect (IE = 0.96, Boot SE = 0.32; Boot LLCI = 0.32,
Boot ULCI = 1.95).
Only ACQ remained a significant mediator when both ACQ and
BSQ scores were included in a multiple parallel mediation model
(ACQ: IE= 0.92,Boot SE=0.33; Boot LLCI= 0.27, BootULCI= 1.98;







VSS-VER (t0) – .32* .27
ACQ (t1) – – .58
BSQ (t1) – – –
BDI–II (t2) – – –
BDI–II (t0) – – –
BAI (t2) – – –
BAI (t0) – – –
Note: t0 indicates baseline; t1, 6-month follow-up; t2, 12-month follow-up.
*p < 0.0025 (Bonferroni correction).
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Copyright © 2018 Wolters Kluwer HULCI = 0.70; model [C]; see Table 4). The combination of the two var-
iables accounted for a CS of 0.11 (BSQ: CS = 0.01; ACQ: CS = 0.10)
after baseline scores of the outcome had been controlled for. In a
pairwise comparison between the specific IEs, body-related cognitions
(ACQ) made a significantly larger contribution than symptom-related
fears (BSQ; IE contrast = 0.86, Boot SE = 0.46; Boot LLCI = 0.05,
Boot ULCI = 1.87). Finally, when the two ACQ subscales were in-
cluded in a multiple parallel mediation model (model [D]; see Table 5),
their combination fully mediated the effect vertigo symptoms had on
depression after baseline depression scores were controlled for, with a
CS of 0.10 indicating a medium effect size. Only for the ACQ subscale
loss of control, the CI of the IE did not include zero (ACQ loss of con-
trol: IE = 0.51, Boot SE = 0.28; Boot LLCI = 0.03, Boot ULCI = 1.47);
although the IE of the ACQ subscale physical crisis was significant on a
5% alpha level, it failed to reach significance when multiple testing was
corrected for (ACQ physical crisis: IE = 0.41, Boot SE = 0.22; Boot
LLCI = −0.01, Boot ULCI = 1.15). In a pairwise comparison between
the specific IEs, neither of the two ACQ subscales made a significantly
larger contribution than the other (IE contrast = −0.10, Boot SE = 0.39;











* .26* .31* .28* .35*
* .62* .54* .56* .55*
.47* .44* .54* .51*
– .75* .70* .58*
– – .57* .72*
– – – .62*
– – – –
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TABLE 4. Symptom-Related Fears (BSQ) and Cognitions (ACQ) as Mediators of the Effect Vertigo Symptoms Exert on Depression (BDI–II)
in a Multiple Mediation Model (N = 210)
Antecedent
Consequent
M1 (BSQ at t1) M2 (ACQ at t1) Y (BDI–II at t2)a
Coeff. SE p Coeff. SE p Coeff. SE p
X (vertigo symptoms at t0) 0.26 0.06 <0.001 0.14 0.03 <0.001 0.42 0.63 0.50
M1 (BSQ at t1) – – – – – – 0.26 0.76 0.74
M2 (ACQ at t1) – – – – – – 6.54 1.55 <0.001
Age 0.00 0.00 0.68 0.00 0.00 0.18 0.04 0.03 0.15
Constant – – – – – – −10.96 2.48 <0.001
R2 = 0.08 R2 = 0.11 R2 = 0.13
F(2,207) = 8.37 F(2,207) = 13.00 F(4,205) = 7.30
p < 0.001 p < 0.001 p < 0.001
Bootstrap results for the IE Effect Boot SE Boot LLCI Boot ULCI
IE through BSQ 0.07 0.22 −0.45 0.70
IE through ACQ 0.92 0.33 0.27 1.98
aResiduals from simple linear regression analysis were entered into mediation analyses to control for BDI–II baseline scores.
Note: X indicates independent variable; Y, outcome variable; M, mediator; Coeff., coefficient; SE, standard error; Boot, bootstrapping; LLCI, lower level of the
98.75% CI; ULCI, upper level of the 98.75% CI.
The Journal of Nervous and Mental Disease • Volume 206, Number 4, April 2018 Fears and Beliefs in DizzinessMediation Analyses Between Vertigo Symptoms
and Anxiety
The results of the simple mediation models analyzing the IE
of vertigo symptoms on anxiety after 1 year through symptom-related
fears and cognitions (models [A] and [B]) showed that both variables
of interest at t1 functioned as significant mediators. With regard to
symptom-related fears (BSQ), the CS amounted to 0.08, indicating a
small effect after baseline BAI scores had been controlled for (IE = 0.96,
Boot SE = 0.33; Boot LLCI = 0.34, Boot ULCI = 2.09).When symptom-
related cognitions (ACQ) were taken into account in a simple mediation
model, aCSof 0.09 indicated amediumeffect (IE=1.09,Boot SE=0.40;
Boot LLCI = 0.29, Boot ULCI = 2.40).TABLE 5. ACQ-Physical Crisis and ACQ Loss of Control as Mediators of t
Multiple Mediation Model (N = 210)
Antecedent
M1 (ACQ Physical Crisis at t1)
Coeff. SE p
X (vertigo symptoms at t0) 0.18 0.04 <0.001
M1 (ACQ physical crisis at t1) – – –
M2 (ACQ loss of control at t1) – – –
Age 0.00 0.00 0.87




Bootstrap results for the IE Effect Boot SE
IE through ACQ physical crisis 0.41 0.22
IE through ACQ loss of control 0.51 0.28
aResiduals from simple linear regression analysis were entered into mediation ana
Note: X indicates independent variable; Y, outcome variable; M, mediator; Coeff
98.75% CI; ULCI, upper level of the 98.75% CI.
© 2018 Wolters Kluwer Health, Inc. All rights reserved.
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and BSQ scores were included in a multiple parallel mediation model
(ACQ: IE = 0.73, Boot SE = 0.41; Boot LLCI = −0.13, Boot
ULCI = 2.08; BSQ: IE = 0.60, Boot SE = 0.29; Boot LLCI = 0.03, Boot
ULCI = 1.56; model [C]; see Table 6). The combination of the two var-
iables accounted for a CS of 0.11 (BSQ: CS = 0.05; ACQ: CS = 0.06)
after BAI baseline scores had been controlled for. The CI of the contrast
of the IEs did not indicate that either of themmade a significantly larger
contribution (IE contrast = −0.13, Boot SE = 0.57; Boot LLCI = −1.32,
Boot ULCI = 0.94).
When the two ACQ subscales were contrasted in a multiple par-
allel mediation model (model [D]; see Table 7), only the ACQ subscale
physical crisis remained a significant mediator (ACQ physical crisis:he Effect Vertigo Symptoms Exert on Depression (BDI–II) in a
Consequent
M2 (ACQ Loss of Control at t1) Y (BDI–II at t2)a
Coeff. SE p Coeff. SE p
0.13 0.04 0.001 0.35 0.62 0.57
– – – 2.45 1.02 0.02
– – – 3.92 1.16 <0.001
0.00 0.00 0.12 0.04 0.03 0.15
– – – −10.38 2.36 <0.001
R2 = 0.08 R2 = 0.13
F(2,207) = 8.55 F(4,205) = 7.84
p < 0.001 p < 0.001
Boot LLCI Boot ULCI
−0.01 1.15
0.03 1.47
lyses to control for BDI–II baseline scores.
., coefficient; SE, standard error; Boot, bootstrapping; LLCI, lower level of the
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TABLE 6. Symptom-Related Fears (BSQ) and Cognitions (ACQ) as Mediators of the Effect Vertigo Symptoms Exert on Anxiety (BAI)
in a Multiple Mediation Model (N = 210)
Antecedent
Consequent
M1 (BSQ at t1) M2 (ACQ at t1) Y (BAI at t2)a
Coeff. SE p Coeff. SE p Coeff. SE p
X (vertigo symptoms at t0) 0.26 0.07 <0.001 0.14 0.03 <0.001 0.22 0.90 0.80
M1 (BSQ at t1) – – – – – – 2.29 1.08 0.03
M2 (ACQ at t1) – – – – – – 5.14 2.20 0.02
Age 0.00 0.00 0.67 0.00 0.00 0.22 0.05 0.04 0.17
Constant – – – – – – −13.94 3.51 <0.001
R2 = 0.07 R2 = 0.11 R2 = 0.11
F(2,207) = 7.95 F(2,207) = 12.20 F(4,205) = 6.09
p < 0.001 p < 0.001 p < 0.001
Bootstrap results for the IE Effect Boot SE Boot LLCI Boot ULCI
IE through BSQ 0.60 0.29 0.03 1.56
IE through ACQ 0.73 0.41 −0.13 2.08
aResiduals from simple linear regression analysis were entered into mediation analyses to control for BAI baseline scores.
Note: X indicates independent variable; Y, outcome variable; M, mediator; Coeff., coefficient; SE, standard error; Boot, bootstrapping; LLCI, lower level of the
98.75% CI; ULCI, upper level of the 98.75% CI.
Radziej et al. The Journal of Nervous and Mental Disease • Volume 206, Number 4, April 2018IE = 1.01, Boot SE = 0.47; Boot LLCI = 0.21, Boot ULCI = 2.60; ACQ
loss of control: IE = 0.20, Boot SE = 0.26; Boot LLCI = −0.46, Boot
ULCI = 1.03). Its CS amounted to 0.08, indicating a small effect. How-
ever, the descriptive difference of the IEs of the ACQ subscales did not
meet criteria for statistical significance (IE contrast = 0.82, Boot
SE = 0.60; Boot LLCI = −0.12, Boot ULCI = 2.31).DISCUSSION
In this study, we examined the role of symptom-related fears and
cognitions as mediators of the longitudinal effect that VD symptoms
exert on symptoms of anxiety and depression after 1 year. The results
across all simple mediation models support our hypothesis that their
association is (at least partly) mediated by both dysfunctional apprehensionsTABLE 7. ACQ Physical Crisis and ACQ Loss of Control as Mediators of t
Mediation Model (N = 210)
Antecedent
M1 (ACQ Physical Crisis at t1)
Coeff. SE p
X (vertigo symptoms at t0) 0.17 0.05 <0.001
M1 (ACQ physical crisis at t1) – – –
M2 (ACQ loss of control at t1) – – –
Age 0.00 0.00 0.91




Bootstrap results for the IE Effect Boot SE
IE through ACQ physical crisis 1.01 0.47
IE through ACQ loss of control 0.20 0.26
aResiduals from simple linear regression analysis were entered into mediation ana
Note: X indicates independent variable; Y, outcome variable; M, mediator; Coeff
98.75% CI; ULCI, upper level of the 98.75% CI.
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Copyright © 2018 Wolters Kluwer Hand fear of physical symptoms after baseline levels of depression and
anxiety had been netted out. More precisely, reacting to physical symp-
toms fearfully and with anxiety-related cognitions such as fear of hav-
ing a crisis or losing control over their body contributed to the process
to develop psychological distress after a VD disorder. Overall, effect
sizes were small to medium; because total effects were small in the first
place, only a limited amount of variance in the outcome variables could
be explained with the models at hand.
With regard to depression, maladaptive cognitions about bodily
sensations made a significantly larger contribution than symptom-
related fears. In particular, a lack of perceived level of control with regard
to symptoms contributed to the development of depression after VD.
With regard to anxiety, body-related fears and cognitions
accounted for a similar amount of the total effect that VD had onhe Effect Vertigo Symptoms Exert on Anxiety (BAI) in a Multiple
Consequent
M2 (ACQ Loss of Control at t1) Y (BAI at t2)a
Coeff. SE p Coeff. SE p
0.13 0.04 0.001 0.11 0.87 0.90
– – – 6.11 1.44 <0.001
– – – 1.47 1.64 0.37
0.00 0.00 0.15 0.05 0.04 0.18
– – – −13.26 3.33 <0.001
R2 = 0.07 R2 = 0.13
F(2,207) = 8.07 F(4,205) = 7.50
p < 0.001 p < 0.001
Boot LLCI Boot ULCI
0.21 2.60
−0.46 1.03
lyses to control for BAI baseline scores.
., coefficient; SE, standard error; Boot, bootstrapping; LLCI, lower level of the
© 2018 Wolters Kluwer Health, Inc. All rights reserved.
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The Journal of Nervous and Mental Disease • Volume 206, Number 4, April 2018 Fears and Beliefs in Dizzinesssecondary anxiety symptoms. This is in linewith the earlier finding that
persistent fear of vertigo and panic-related thoughts predicted the devel-
opment of secondary panic disorder in a subgroup of VD patients with
vestibular neuritis (Godemann et al., 2006); however, in our sample,
only symptom-related fears remained a significant mediator when
cognitions were controlled for. When taking a closer look at the
ACQ subscales, only the anticipation of a physical crisis but not loss
of control was a significant mediator when statistically controlling
for the other subscale, even though the comparison failed to reach
statistical significance.
Although the role of somatic symptom-related fears and
cognitions has been well researched in functional VD and further
somatoform disorders (Martin and Rief, 2011), the results at hand
suggest that they come into effect irrespective of the VD symptoms’ eti-
ology. More importantly, the observation that symptom-related fears
and cognitions mediate the effect VD had on psychological distress
was not limited to patients with a nonorganic cause of their symptoms,
but occurred across a wide range of diagnoses. Conforming to Tschan
et al. (2010), high scores on the ACQ and BSQ scales were not limited
to functional VD patients; in their validation study of the German
Vertigo Handicap Questionnaire, those two scales did not differenti-
ate between patients with functional versus organic VD. In line with
this, Pollak et al. (2012) showed that even in an organic VD disorder
with a clear understanding of its cause and straightforward treatment,
benign paroxysmal positional vertigo, there appears to be a surprising
rigidity of feelings and beliefs toward the illness even after treatment.
The results give rise to the question in what way dysfunctional
cognitions and fears contribute to the development of psychological
distress. In their cognitive behavioral model of persistent postural-
perceptual dizziness, Whalley and Cane (2017) outline psychological
processes in the development and maintenance of the disorder that show
similarities to cognitive models of health anxiety and panic disorder.
They stress the role of a) unhelpful appraisals, b) avoidance and safety
behaviors, and c) attentional strategies such as selective attention to
body sensations in the maintenance of dizziness that can be triggered
by both organic and nonspecific VD episodes. Our results suggest
that those mechanisms might come into play not only in the perpetu-
ation of dizziness (Heinrichs et al., 2007) but also in the development
of further psychopathology.
Negative perceptions and fear of somatic symptoms may lead to
the avoidance of a range of activities and physical demands (Yardley,
1994a), a mechanism that has commonly been noted in panic and
phobia and inspired similar treatment strategies (Edelman et al.,
2012). In fact, many patients with anxiety disorders specified VD
as the most anxiety-provoking and uncomfortable sensations among
the bodily sensations that may be caused by panic attacks (Asmundson
et al., 1998).
Although the interplay between vestibular disorders and anxiety
has repeatedly been pointed out, the association with symptoms of de-
pression seems somewhat less apparent. Nakao and Yano (2006) found
that dizziness is a significant predictor of depression, with the mediat-
ing processes remaining unclear. With regard to our results, symptom-
related cognitions, loss of control in particular, might play a greater role
in the development of depression compared with anxiety after VD. Pa-
tients may become passive, withdrawn, or excessively help-seeking if
they feel they are not in control of their symptoms and have a low
perceived self-efficacy. Indeed, in their longitudinal study with pa-
tients with recurrent vertigo, Yardley (1994b) found that handicap
was negatively related to internal locus of control and positively cor-
related with relinquishing responsibility.
On a positive note, negative beliefs about the consequences
of VD can be subject to modification in cognitive psychotherapy
(Yardley et al., 2001). Dysfunctional fears and beliefs related to so-
matic sensations can be targeted both implicitly and explicitly: the par-
allels between vestibular rehabilitation and interoceptive exposure to© 2018 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2018 Wolters Kluwer Hfeared sensations in cognitive behavioural therapy have been outlined
before (Staab, 2011). By testing the validity of fears about VD, they
not only promote psychological habituation to the symptom but can
also build confidence in the predictability and controllability of symp-
toms. In addition, beliefs about VD can be challenged explicitly via
cognitive restructuring. Providing an adequate appraisal of VD symp-
toms might be helpful in preventing secondary depressive and anxiety
symptoms from developing and exacerbating in patients with various
vestibular disorders.
Focusing on protective instead of risk factors, Tschan et al. (2011)
found that patients who reported resilient coping and a higher sense of
coherence were indeed less likely to develop a comorbid mental disorder
1 year after vestibular disease.
Strengths and Limitations
To our knowledge, this is the first study to investigate how
symptom-related fears and beliefs contribute to the effect VD symptoms
longitudinally exert on the development of anxiety and depression. The
large sample includes patients with a wide range of vestibular disorders,
and measurements cover a follow-up period over 1 year.
However, the study does have some methodological short-
comings. First, given the correlational and nonexperimental design
of the study, no causal interpretation can be made with certainty at
this stage; in light of this, results should be interpreted cautiously.
Second, the study was conducted in a tertiary care setting (i.e., a
highly specialized outpatient clinic for vertigo and balance disorders)
and therefore may have involved selection bias. In addition, because pa-
tients who were excluded from analyses due to missing data or loss at
follow-up were significantly younger, the current sample is not fully
representative for the patients’ group of interest. However, the general-
izability of the results might not be too strongly impaired as the age dif-
ference amounted to a small effect size only and age did not influence
the results of the mediation models.
Third, the study focuses on somatic symptom-related fears and
cognitions, not taking into account overall illness beliefs, that is, as-
sumptions about the cause, course, and the expected response to treat-
ment as well as controllability of the illness itself (not its symptoms).
These illness perceptions may add to the way people cope with and re-
spond emotionally to an illness; they have been shown to affect health-
related quality of life and predict long-term outcome (Frostholm et al.,
2007). However, we did concentrate on symptom cognitions in light of
the heterogeneity of diagnoses, thereby considering that, for instance,
the expectation of an illness to be long-lasting might be the result
of a cognitive distortion in some patients or an unfortunately correct
assumption in certain diagnostic groups such as Ménière’s disease.
Fourth, it was pointed out that there is partial item overlap be-
tween the mediator and outcome measures that might have introduced
bias; when analyses were repeated without respective items (specifi-
cally, items 5, 14, and 16 from the BAI), significance and effect size
of the IEs did not change.
A final point of potential critique lies within the study design:
measures of somatic symptom-related fears and beliefs at the first fol-
low-up after 6 months were analyzed as mediator variables of interest.
One might argue that those appraisals and fearful responses appear in
closer time proximity after VD symptoms. However, the analyses
yielded comparable results if baseline scores of the respective variables
were entered into mediation models; the results are available from the
author upon request.
CONCLUSION
Fear of bodily sensations and dysfunctional cognitions about
these symptoms longitudinally contribute to the effect that initial
vertigo and dizziness symptoms, irrespective of their etiology, have
on the development of anxiety and depression. These findings arewww.jonmd.com 283
ealth, Inc. All rights reserved.
Radziej et al. The Journal of Nervous and Mental Disease • Volume 206, Number 4, April 2018compatiblewith cognitive-behavioral models of psychological sequelae
after VD disorders and point to the potential benefits of interventions to
modify specific symptom-related beliefs and fears via different kinds of
psychotherapies such as cognitive behavioural therapy.DISCLOSURE
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